Topics

Last Month in Oncology with Dr. Bishal Gyawali: April 2019

06:05 EDT 2 May 2019 | ecancermedicalscience

Keynote speech on the JAVELIN not going far enough to improve survival The treatment landscape for metastatic renal-cell carcinoma has changed dramatically with the introduction of immunotherapies. Unfortunately though, we are promoting combinations over...

Original Article: Last Month in Oncology with Dr. Bishal Gyawali: April 2019

NEXT ARTICLE

More From BioPortfolio on "Last Month in Oncology with Dr. Bishal Gyawali: April 2019"

Quick Search